KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Other Non-Current Liabilities (2016 - 2025)

Medpace Holdings' Other Non-Current Liabilities history spans 11 years, with the latest figure at $57.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 34.92% year-over-year to $57.7 million; the TTM value through Dec 2025 reached $57.7 million, up 34.92%, while the annual FY2025 figure was $57.7 million, 34.92% up from the prior year.
  • Other Non-Current Liabilities reached $57.7 million in Q4 2025 per MEDP's latest filing, up from $54.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $57.7 million in Q4 2025 to a low of $16.1 million in Q3 2021.
  • Average Other Non-Current Liabilities over 5 years is $29.3 million, with a median of $23.0 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: rose 2.16% in 2021, then skyrocketed 82.07% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $17.7 million in 2021, then grew by 27.93% to $22.7 million in 2022, then rose by 24.32% to $28.2 million in 2023, then soared by 51.43% to $42.7 million in 2024, then surged by 34.92% to $57.7 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Other Non-Current Liabilities are $57.7 million (Q4 2025), $54.5 million (Q3 2025), and $51.9 million (Q2 2025).